
<!DOCTYPE html>
<html>
    <head>
        <title>【国盛医药】AlnylamsiRNA疗法PatisiranwtATTR疗效积极，大涨48%8月3日，RNAi疗法龙头AlnylamPharmaceuticals宣布Patisiran治疗转甲状腺素蛋白淀粉样变性（ATTR）的3期临床获得了积极数据。</title>
        <meta charset="utf-8" />
    </head>
    <body>
        <div class="note-wrapper">
            <h1>【国盛医药】AlnylamsiRNA疗法PatisiranwtATTR疗效积极，大涨48%8月3日，RNAi疗法龙头AlnylamPharmaceuticals宣布Patisiran治疗转甲状腺素蛋白淀粉样变性（ATTR）的3期临床获得了积极数据。</h1>
			<button class="btn btn-primary"><a href="../index.html">返回主页</a></button><br><br>
			【国盛医药】AlnylamsiRNA疗法PatisiranwtATTR疗效积极，大涨48%8月3日，RNAi疗法龙头AlnylamPharmaceuticals宣布Patisiran治疗转甲状腺素蛋白淀粉样变性（ATTR）的3期临床获得了积极数据。<br><br>作为全球首款siRNA药物，Patisiran最早于2018年10月被FDA批准上市用于治疗遗传性ATTR，对应患者数约5万人。RNAi疗法能直击ATTR病因，特异性沉默TTR表达，减少淀粉样TTR蛋白的异常积累；且作用机制可逆，疗效更加灵活。本次披露研究的适应症更覆盖了野生型ATTR，全球潜在患者人群可达20-30万人，长效RNAi疗法在较大适应症中看到了明确的发展潜力。在此催化下Alnylam当日市值迅速拉升了接近50%。<br><br>目前5款上市的siRNA疗法均来自Alnylam，研究已表明RNAi可用于心脑血管、中枢神经、肿瘤、病毒性感染等疾病领域，长效作用优势能大大提升产品使用顺应性，极具替代潜力，2030年全球和中国市场规模有望分别达到250亿、30亿美元。<br><br>国内企业中，圣诺医药全球首次以RNAi疗法在肿瘤领域取得积极IIa期临床结果（STP705，原位鳞状细胞癌），6项全球临床试验覆盖肿瘤、瘢痕、胆管炎等适应症；翰森制药2021年10月先后2次引入siRNA疗法，合计交易金额超过17.5亿美元；此外布局RNAi平台的公司还包括腾盛博药（BRII-835，乙肝）、歌礼制药、君实生物、恒瑞医药、瑞博生物、舒泰神（STSG-0002，乙肝）、舶望制药等。小核酸CDMO企业则主要包括药明康德、凯莱英、金斯瑞、博腾股份等。<br><br>#文字纪要#
            <br><br><button class="btn btn-primary"><a href="../index.html">返回主页</a></button>

        </div>
        <script type="text/javascript">
            (function() {

    var doc_ols = document.getElementsByTagName("ol");

    for ( i=0; i<doc_ols.length; i++) {

        var ol_start = doc_ols[i].getAttribute("start") - 1;
        doc_ols[i].setAttribute("style", "counter-reset:ol_counter " + ol_start + ";");

    }

})();

        </script>
        <style>
            html,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,b,u,i,center,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td,article,aside,canvas,details,embed,figure,figcaption,footer,header,hgroup,menu,nav,output,ruby,section,summary,time,mark,audio,video{margin:0;padding:0;border:0;font:inherit;font-size:100%;vertical-align:baseline}html{line-height:1}ol,ul{list-style:none}table{border-collapse:collapse;border-spacing:0}caption,th,td{text-align:left;font-weight:normal;vertical-align:middle}q,blockquote{quotes:none}q:before,q:after,blockquote:before,blockquote:after{content:"";content:none}a img{border:none}article,aside,details,figcaption,figure,footer,header,hgroup,main,menu,nav,section,summary{display:block}*{-moz-box-sizing:border-box;-webkit-box-sizing:border-box;box-sizing:border-box}html{font-size:87.5%;line-height:1.57143em}html{font-size:14px;line-height:1.6em;-webkit-text-size-adjust:100%}body{background:#fcfcfc;color:#545454;text-rendering:optimizeLegibility;font-family:"AvenirNext-Regular"}a{color:#de4c4f;text-decoration:none}h1{font-family:"AvenirNext-Medium";color:#333;font-size:1.6em;line-height:1.3em;margin-bottom:.78571em}h2{font-family:"AvenirNext-Medium";color:#333;font-size:1.3em;line-height:1em;margin-bottom:.62857em}h3{font-family:"AvenirNext-Medium";color:#333;font-size:1.15em;line-height:1em;margin-bottom:.47143em}p{margin-bottom:1.57143em;hyphens:auto}hr{height:1px;border:0;background-color:#dedede;margin:-1px auto 1.57143em auto}ul,ol{margin-bottom:.31429em}ul ul,ul ol,ol ul,ol ol{margin-bottom:0px}ol{counter-reset:ol_counter}ol li:before{content:counter(ol_counter) ".";counter-increment:ol_counter;color:#e06e73;text-align:right;display:inline-block;min-width:1em;margin-right:0.5em}b,strong{font-family:"AvenirNext-Bold"}i,em{font-family:"AvenirNext-Italic"}code{font-family:"Menlo-Regular"}.text-overflow-ellipsis{overflow:hidden;text-overflow:ellipsis;white-space:nowrap}.sf_code_string,.sf_code_selector,.sf_code_attr-name,.sf_code_char,.sf_code_builtin,.sf_code_inserted{color:#D33905}.sf_code_comment,.sf_code_prolog,.sf_code_doctype,.sf_code_cdata{color:#838383}.sf_code_number,.sf_code_boolean{color:#0E73A2}.sf_code_keyword,.sf_code_atrule,.sf_code_rule,.sf_code_attr-value,.sf_code_function,.sf_code_class-name,.sf_code_class,.sf_code_regex,.sf_code_important,.sf_code_variable,.sf_code_interpolation{color:#0E73A2}.sf_code_property,.sf_code_tag,.sf_code_constant,.sf_code_symbol,.sf_code_deleted{color:#1B00CE}.sf_code_macro,.sf_code_entity,.sf_code_operator,.sf_code_url{color:#920448}.note-wrapper{max-width:46em;margin:0px auto;padding:1.57143em 3.14286em}.note-wrapper.spotlight-preview{overflow-x:hidden}u{text-decoration:none;background-image:linear-gradient(to bottom, rgba(0,0,0,0) 50%,#e06e73 50%);background-repeat:repeat-x;background-size:2px 2px;background-position:0 1.05em}s{color:#878787}p{margin-bottom:0.1em}hr{margin-bottom:0.7em;margin-top:0.7em}ul li{text-indent:-0.35em}ul li:before{content:"•";color:#e06e73;display:inline-block;margin-right:0.3em}ul ul{margin-left:1.25714em}ol li{text-indent:-1.45em}ol ol{margin-left:1.25714em}blockquote{display:block;margin-left:-1em;padding-left:0.8em;border-left:0.2em solid #e06e73}.todo-list ul{margin-left:1.88571em}.todo-list li{text-indent:-1.75em}.todo-list li:before{content:"";display:static;margin-right:0px}.todo-checkbox{text-indent:-1.7em}.todo-checkbox svg{margin-right:0.3em;position:relative;top:0.2em}.todo-checkbox svg #check{display:none}.todo-checkbox.todo-checked #check{display:inline}.todo-checkbox.todo-checked+.todo-text{text-decoration:line-through;color:#878787}.code-inline{display:inline;background:white;border:solid 1px #dedede;padding:0.2em 0.5em;font-size:0.9em}.code-multiline{display:block;background:white;border:solid 1px #dedede;padding:0.7em 1em;font-size:0.9em;overflow-x:auto}.hashtag{display:inline-block;color:white;background:#b8bfc2;padding:0.0em 0.5em;border-radius:1em;text-indent:0}.hashtag a{color:#fff}.address a{color:#545454;background-image:linear-gradient(to bottom, rgba(0,0,0,0) 50%,#0da35e 50%);background-repeat:repeat-x;background-size:2px 2px;background-position:0 1.05em}.address svg{position:relative;top:0.2em;display:inline-block;margin-right:0.2em}.color-preview{display:inline-block;width:1em;height:1em;border:solid 1px rgba(0,0,0,0.3);border-radius:50%;margin-right:0.1em;position:relative;top:0.2em;white-space:nowrap}.color-code{margin-right:0.2em;font-family:"Menlo-Regular";font-size:0.9em}.color-hash{opacity:0.4}.ordered-list-number{color:#e06e73;text-align:right;display:inline-block;min-width:1em}.arrow svg{position:relative;top:0.08em;display:inline-block;margin-right:0.15em;margin-left:0.15em}.arrow svg #rod{stroke:#545454}.arrow svg #point{fill:#545454}mark{color:inherit;display:inline;padding:0.2em 0.5em;background-color:#fcffc0}img{max-width:100%;height:auto}
        </style>
    </body>
</html>
